← All companies

VCEL Vericel Corporation

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · $2.1B market cap · updated 2026-10-06
Market price
$41.07
Avg intrinsic value
$0.00
Margin of safety
—

Three independent discounted-cash-flow-style models value Vericel Corporation every trading day. 0 of 3 currently price VCEL above its market price.

Model estimates

Free Cash Flow model$-31.41
Excess Profit model$-10.97
Residual Earnings model$-1.18
Dividend Discount model—

Quality snapshot

Piotroski F-Score8 / 9
Return on invested capital+2.0%
Net debt / EBITDA-1.4×
Gross margin+74.4%
Revenue CAGR+18.9%
Cash conversion3.1×
Dividend yield—
Buyback yield-3.1%

Run your own numbers

These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.

Open VCEL in StockKitty

Same sector